Annual Total Long Term Liabilities
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, CNTX annual total long term liabilities is $0.00, unchanged on December 31, 2023.
- During the last 3 years, CNTX annual total long term liabilities has fallen by -$7.84 million (-100.00%).
- CNTX annual total long term liabilities is now -100.00% below its all-time high of $7.84 million, reached on December 31, 2020.
Performance
CNTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$140.20 K
+$140.20 K+100.00%
September 1, 2024
Summary
- As of February 7, 2025, CNTX quarterly total long term liabilities is $140.20 thousand, with the most recent change of +$140.20 thousand (+100.00%) on September 1, 2024.
- Over the past year, CNTX quarterly long term liabilities has increased by +$140.20 thousand (+100.00%).
- CNTX quarterly long term liabilities is now -99.33% below its all-time high of $21.06 million, reached on June 30, 2021.
Performance
CNTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CNTX Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | 0.0% | +100.0% |
3 y3 years | -100.0% | +100.0% |
5 y5 years | -100.0% | +100.0% |
CNTX Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | at low | at high | -100.0% |
5 y | 5-year | -100.0% | at low | -99.3% | -100.0% |
alltime | all time | -100.0% | at low | -99.3% | -100.0% |
Context Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $140.20 K(>+9900.0%) |
Jun 2024 | - | $0.00(0.0%) |
Mar 2024 | - | $0.00(0.0%) |
Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2023 | - | $0.00(0.0%) |
Jun 2023 | - | $0.00(0.0%) |
Mar 2023 | - | $0.00(0.0%) |
Dec 2022 | $0.00 | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $0.00(-100.0%) |
Jun 2022 | - | $8000.00(-74.8%) |
Mar 2022 | - | $31.70 K(>+9900.0%) |
Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2021 | - | $21.06 M(0.0%) |
Jun 2021 | - | $21.06 M(+28.5%) |
Mar 2021 | - | $16.39 M(+109.1%) |
Dec 2020 | $7.84 M(+6122.5%) | $7.84 M |
Dec 2019 | $126.00 K | - |
FAQ
- What is Context Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Context Therapeutics?
- What is Context Therapeutics annual total long term liabilities year-on-year change?
- What is Context Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Context Therapeutics?
- What is Context Therapeutics quarterly long term liabilities year-on-year change?
What is Context Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CNTX is $0.00
What is the all time high annual total long term liabilities for Context Therapeutics?
Context Therapeutics all-time high annual total long term liabilities is $7.84 M
What is Context Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CNTX annual total long term liabilities has changed by $0.00 (0.00%)
What is Context Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CNTX is $140.20 K
What is the all time high quarterly long term liabilities for Context Therapeutics?
Context Therapeutics all-time high quarterly total long term liabilities is $21.06 M
What is Context Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CNTX quarterly total long term liabilities has changed by +$140.20 K (+100.00%)